The global Pressurized Intraperitoneal Aerosol Chemotherapy Devices Market is experiencing significant growth as healthcare providers increasingly adopt advanced treatment technologies for peritoneal cancers. Driven by rising cancer prevalence, expanding clinical research, and growing demand for minimally invasive oncology procedures, the market is projected to witness strong expansion over the coming decade.